Higher concentration of trehalose dihydrate stabilizes recombinant IgG1 under forced stress conditions

IF 3.8 3区 医学 Q2 CHEMISTRY, MEDICINAL Journal of pharmaceutical sciences Pub Date : 2025-02-01 Epub Date: 2025-01-10 DOI:10.1016/j.xphs.2024.12.017
Deepika Sarin , Debasmita Chakraborty , Shravan Sreenivasan , Avinash Mishra , Anurag S. Rathore
{"title":"Higher concentration of trehalose dihydrate stabilizes recombinant IgG1 under forced stress conditions","authors":"Deepika Sarin ,&nbsp;Debasmita Chakraborty ,&nbsp;Shravan Sreenivasan ,&nbsp;Avinash Mishra ,&nbsp;Anurag S. Rathore","doi":"10.1016/j.xphs.2024.12.017","DOIUrl":null,"url":null,"abstract":"<div><div>Stability of complex biotherapeutics like monoclonal antibodies is paramount for their safe and efficacious use. Excipients are inactive ingredients that are added to the purified product so as to offer it a stable environment. Trehalose dihydrate is a non-reducing sugar that is commonly used as a stabilizing agent in biotherapeutic formulations under liquid and frozen states. The stabilizing effect of trehalose against aggregation in protein formulations is well known. The present study aims to offer insights into the stability effects of higher trehalose concentration (230 mM) on liquid trastuzumab under different forced stress conditions including thermal, light with and without hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), humidity and extraction stresses. Under thermal stress, while high molecular weight (HMW) accounted for 38.80 % in the trastuzumab sample without trehalose, it was 4.89 % at high trehalose concentration. Similarly, under light stress with H<sub>2</sub>O<sub>2</sub>, the trastuzumab sample without trehalose had &gt;80 % more HMW than at high trehalose concentration. Two other IgG1 mAbs (rituximab and bevacizumab) were also evaluated for stability at higher trehalose concentrations (230 mM). Similar to trastuzumab, stabilization was observed under thermal stress for rituximab and bevacizumab at higher trehalose concentration compared to samples without trehalose (21.90 % and 29.90 % HMW, respectively). Likewise, accelerated (under humidity stress) and extraction stress induced secondary and tertiary structure disruptions were reduced at higher trehalose concentration. An in-silico study between binding interactions of trehalose and trastuzumab Fab region at different concentrations depicted an increase in hydrogen bonding with trastuzumab Fab when the trehalose concentration is increased, thereby reducing aggregation. Overall, mAb stability under forced stress conditions improved significantly at higher trehalose concentrations. While higher trehalose concentration (&gt;200 mM) is used in mAb formulations and is known to minimise aggregation under thermal stress, however, the current study aims to also explore the stability imparted under light (with H<sub>2</sub>O<sub>2</sub>), humidity and extraction stresses for three different mAbs and attempts to explain the underlying mechanisms via in-silico studies.</div></div>","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":"114 2","pages":"Pages 1398-1409"},"PeriodicalIF":3.8000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022354924006300","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Stability of complex biotherapeutics like monoclonal antibodies is paramount for their safe and efficacious use. Excipients are inactive ingredients that are added to the purified product so as to offer it a stable environment. Trehalose dihydrate is a non-reducing sugar that is commonly used as a stabilizing agent in biotherapeutic formulations under liquid and frozen states. The stabilizing effect of trehalose against aggregation in protein formulations is well known. The present study aims to offer insights into the stability effects of higher trehalose concentration (230 mM) on liquid trastuzumab under different forced stress conditions including thermal, light with and without hydrogen peroxide (H2O2), humidity and extraction stresses. Under thermal stress, while high molecular weight (HMW) accounted for 38.80 % in the trastuzumab sample without trehalose, it was 4.89 % at high trehalose concentration. Similarly, under light stress with H2O2, the trastuzumab sample without trehalose had >80 % more HMW than at high trehalose concentration. Two other IgG1 mAbs (rituximab and bevacizumab) were also evaluated for stability at higher trehalose concentrations (230 mM). Similar to trastuzumab, stabilization was observed under thermal stress for rituximab and bevacizumab at higher trehalose concentration compared to samples without trehalose (21.90 % and 29.90 % HMW, respectively). Likewise, accelerated (under humidity stress) and extraction stress induced secondary and tertiary structure disruptions were reduced at higher trehalose concentration. An in-silico study between binding interactions of trehalose and trastuzumab Fab region at different concentrations depicted an increase in hydrogen bonding with trastuzumab Fab when the trehalose concentration is increased, thereby reducing aggregation. Overall, mAb stability under forced stress conditions improved significantly at higher trehalose concentrations. While higher trehalose concentration (>200 mM) is used in mAb formulations and is known to minimise aggregation under thermal stress, however, the current study aims to also explore the stability imparted under light (with H2O2), humidity and extraction stresses for three different mAbs and attempts to explain the underlying mechanisms via in-silico studies.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高浓度的海藻糖二水合物在胁迫条件下稳定重组IgG1。
单克隆抗体等复杂生物治疗药物的稳定性对其安全有效的使用至关重要。赋形剂是添加到纯化产品中的非活性成分,以便为其提供稳定的环境。二水海藻糖是一种非还原糖,通常用作液体和冷冻状态下生物治疗制剂中的稳定剂。海藻糖在蛋白质配方中抗聚集的稳定作用是众所周知的。本研究旨在深入了解高海藻糖浓度(230 mM)对曲妥珠单抗液体在不同强迫应力条件下的稳定性影响,包括热、光、湿度和提取应力。在热应激下,无海藻糖的曲妥珠单抗样品高分子量(HMW)占38.80%,高海藻糖浓度时为4.89%。同样,在H2O2的光胁迫下,不含海藻糖的曲妥珠单抗样品的HMW比高浓度海藻糖高80%。另外两种IgG1单抗(利妥昔单抗和贝伐单抗)在较高海藻糖浓度(230 mM)下的稳定性也进行了评估。与曲妥珠单抗类似,与不含海藻糖的样品相比,在更高海藻糖浓度下,利妥昔单抗和贝伐单抗在热应激下表现出稳定性(分别为21.90%和29.90% HMW)。同样,在较高的海藻糖浓度下,加速(在湿度应力下)和提取应力引起的二级和三级结构破坏减少。一项关于不同浓度海藻糖和曲妥珠单抗Fab区结合相互作用的计算机研究表明,当海藻糖浓度增加时,曲妥珠单抗Fab区与氢键的结合增加,从而减少聚集。总体而言,在较高海藻糖浓度下,mAb在强迫胁迫条件下的稳定性显著提高。虽然在单克隆抗体配方中使用较高的海藻糖浓度(bb0 - 200 mM),并且已知可以最大限度地减少热应力下的聚集,但是,目前的研究还旨在探索三种不同单克隆抗体在光(H2O2)、湿度和提取应力下的稳定性,并试图通过硅研究来解释潜在的机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
7.30
自引率
13.20%
发文量
367
审稿时长
33 days
期刊介绍: The Journal of Pharmaceutical Sciences will publish original research papers, original research notes, invited topical reviews (including Minireviews), and editorial commentary and news. The area of focus shall be concepts in basic pharmaceutical science and such topics as chemical processing of pharmaceuticals, including crystallization, lyophilization, chemical stability of drugs, pharmacokinetics, biopharmaceutics, pharmacodynamics, pro-drug developments, metabolic disposition of bioactive agents, dosage form design, protein-peptide chemistry and biotechnology specifically as these relate to pharmaceutical technology, and targeted drug delivery.
期刊最新文献
Stabilization of supersaturation for enhanced oral absorption of a BCS II drug efonidipine hydrochloride: Eudragit® L100-55-based amorphous solid dispersions A quantitative metric of immune responses with applications in vaccines, cancer immunity, autoimmunity, and anti-drug antibody monitoring Comprehensive stress study on recombinant adeno-associated virus vectors: Evaluating the capabilities of established analytical techniques Industry guidance on container closure integrity strategies for difficult-to-test parenteral products (DTPs) Impact of spacer chain length on self-assembly of paclitaxel-biotin conjugates
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1